
|Videos|February 11, 2019
Expert Highlights Areas of Research in MCL
Author(s)Krish Patel, MD
Krish Patel, MD, discusses the areas of research he finds particularly interesting for the treatment of patients with mantle cell lymphoma.
Advertisement
Krish Patel, MD, an oncologist at the Swedish Cancer Institute, discusses the areas of research he finds particularly interesting for the treatment of patients with mantle cell lymphoma (MCL).
Moving forward, Patel thinks it will be interesting to see how CAR T-cell therapy evolves in this space. This is an exciting area of research for MCL, as well as the other lymphoid malignancies where these agents are also being investigated. However, it is too early to know the ultimate impact of this research.
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Approves Subcutaneous Amivantamab for EGFR-Mutated NSCLC Indications
2
Enfortumab Vedotin Plus Pembrolizumab Improves Survival in MIBC
3
FDA Grants Regular Approval to Rucaparib for BRCA-Mutated mCRPC
4
Long-Term ECHO Data Support Concurrent Acalabrutinib/BR in MCL
5








































